Comparative Table of Core and Complementary Medicines on the WHO Essential Medicines List from 1977- 2011
Developed by Aziz Jafarov, Tulip Schneider, Brenda Waning, Sharon Hems, Rianne van den Ham, Esprit Ma, , Li Jie Wang, and Richard Laing 

ITEM
1.  ANAESTHETICS                                                                                                                                                                                                                                                     
1.1 General anaesthetics and oxygen                                                                                                                                                                                                                                         
1.11 Inhalational medicines                                                                                                                                                                                                                                       
ether, anaesthetic
halothane
isoflurane 
nitrous oxide
oxygen
1.12 Injectable medicines                                                                                                                                                                                                                                       
ketamine
propofol 
*thiopental
1.2 Local anaesthetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
*bupivacaine
*lidocaine (D) 
lidocaine  + epinephrine (adrenaline)
ephedrine
1.3 Preoperative medication and sedation for short-term procedures                                                                                                                                                                                                                                          
atropine (D)
chloral hydrate
*diazepam (D) 
*midazolam
morphine (D) 
promethazine (D)
1. TOTAL(core)
1. TOTAL

2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS IN RHEUMATOID DISORDERS (DMARDs)
2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)                                                                                                                                                                                                                                                              
acetylsalicylic acid (D)
ibuprofen (a) (D)
paracetamol (D) 
acetylsalicylic acid*(C) (D)
colchicine
*probenecid
2.2 Opioid analgesics                                          
codeine (D) 
morphine (D) 
*pethidine
2.3 Medicines used to treat gout
allopurinol (D)
colchicine
2.4 Disease modifying agents used in rheumatoid disorders (DMARDs)
azathioprine (D)
chloroquine (D) 
cyclophosphamide
methotrexate (D)
penicillamine (D)
sulfasalazine (D)
azathioprine (D)
hydroxychloroquine
methotrexate (D) 
penicillamine (D) 
sulfasalazine (D)
2. TOTAL(core)
2. TOTAL

3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
*chlorphenamine (a)
dexamethasone (D) 
epinephrine (adrenaline) (D) 
hydrocortisone (D) 
*prednisolone (D)
cromoglicic acid
3. TOTAL(core)
3. TOTAL

4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
4.1 Non-specific
charcoal, activated
ipecacuanha
4.2 Specific
acetylcysteine
atropine (D)
calcium gluconate (D)
deferoxamine
dimercaprol
DL-methionine
methylthioninium chloride (methylene blue)
naloxone
penicillamine (D) 
potassium ferric hexacyanoferrate (II) 2H2O (Prussian blue)
sodium calcium edetate
sodium nitrite
sodium thiosulfate (D)
methylthioninium chloride
penicillamine 
sodium calcium edetate
deferoxamine
dimercaprol
succimer
4. TOTAL(core)
4. TOTAL

5. ANTICONVULSANTS/ANTIEPILEPTICS
carbamazepine (D)
diazepam (D) 
* lorazepam
ethosuximide
magnesium sulfate
phenobarbital
phenytoin
valproic acid (D)
carbamazepine
*clonazepam
ethosuximide
magnesium sulfate
valproic acid
5. TOTAL(core)
5. TOTAL

6. ANTI-INFECTIVE MEDICINES
6.1 Anthelminthics
6.1.1 Intestinal anthelminthics
albendazole
levamisole
mebendazole
niclosamide
praziquantel (D) 
pyrantel
blephenium hydroxynaphthoate
levamisole
tetrachlorothylene
6.1.2 Antifilarials
albendazole (D)
diethylcarbamazine
ivermectin
diethylcarbamazine
ivermectin
suramin sodium (D)
6.1.3 Antischistosomals and antitrematode medicine
metrifonate
oxamniquine
praziquantel (D) 
triclabendazole
oxamniquine
sodium stibocaptate
6.2 Antibacterials
6.2.1 Beta Lactam medicines
*ceftriaxone (a)
*cloxacillin
amoxicillin
amoxicillin + clavulanic acid
ampicillin
benzathine benzylpenicillin
benzylpenicillin
Cefalexin ( C)
cefalozin (a)
cefixime
ceftazidime
imipenem + cilastatin
phenoxymethylpenicillin
procaine benzylpenicillin
amoxicillin + clavulanic acid
cefotaxime [c]
ceftazidime
*ceftriaxone
imipenem + cilastatin
6.2.2 Other antibacterials
azithromycin
clarithromycin
chloramphenicol
*ciprofloxacin (D)
doxycycline (a) (D) 
*erythromycin
*gentamicin (D) 
*metronidazole (D) 
nalidixic acid
nitrofurantoin
spectinomycin
sulfadiazine
sulfamethoxazole + trimethoprim (D)
trimethoprim (a)
vancomycin
amikacin
chloramphenicol
*ciprofloxacin
clindamycin
doxycycline
nalidixic acid
nitrofurantoin
procaine benzylpenicillin
sulfadiazine
trimethoprim
vancomycin
6.2.3 Antileprosy medicines
Medicines used in the treatment of leprosy should never be used except in combination. Combination therapy is essential to prevent the emergence of drug resistance. Colour coded blister packs (MDT blister packs) containing standard two medicine (paucibacillary leprosy) or three medicine (multibacillary leprosy) combinations for adult and childhood leprosy should be used. MDT blister packs can be supplied free of charge through WHO.
clofazimine
dapsone
rifampicin (D)
clofazimine
ethionamide
protionamide
rifampicin
6.2.4 Antituberculosis medicines
ethambutol
ethambutol + isoniazid 
ethambutol+ isoniazid+  rifampicin 
isoniazid
pyrazinamide
rifabutin
rifampicin (D)
rifampicin + isoniazid
rifampicin + isoniazid + pyrazinamide
rifampicin + isoniazid + pyrazinamide + ethambutol
streptomycin
Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
thioacetazone
thioacetazone + isoniazid
Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control
amikacin
p-aminosalicylic acid
capreomycin
ciprofloxacin (D) 
cycloserine
ethionamide
kanamycin
levofloxacin
ofloxacin
6.3 Antifungal medicines
amphotericin B (D)
clotrimazole
*fluconazole
griseofulvin
*ketoconazole
nystatin
amphotericin B (D)
flucytosineComparative Table of Core and Complementary Medicines on the WHO Essential Medicines List from 1977- 2011
Developed by Aziz Jafarov, Tulip Schneider, Brenda Waning, Sharon Hems, Rianne van den Ham, Esprit Ma, , Li Jie Wang, and Richard Laing 

ITEM
1.  ANAESTHETICS                                                                                                                                                                                                                                                     
1.1 General anaesthetics and oxygen                                                                                                                                                                                                                                         
1.11 Inhalational medicines                                                                                                                                                                                                                                       
ether, anaesthetic
halothane
isoflurane 
nitrous oxide
oxygen
1.12 Injectable medicines                                                                                                                                                                                                                                       
ketamine
propofol 
*thiopental
1.2 Local anaesthetics                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
*bupivacaine
*lidocaine (D) 
lidocaine  + epinephrine (adrenaline)
ephedrine
1.3 Preoperative medication and sedation for short-term procedures                                                                                                                                                                                                                                          
atropine (D)
chloral hydrate
*diazepam (D) 
*midazolam
morphine (D) 
promethazine (D)
1. TOTAL(core)
1. TOTAL

2. ANALGESICS, ANTIPYRETICS, NON-STEROIDAL ANTI-INFLAMMATORY MEDICINES (NSAIMs), MEDICINES USED TO TREAT GOUT AND DISEASE MODIFYING AGENTS IN RHEUMATOID DISORDERS (DMARDs)
2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs)                                                                                                                                                                                                                                                              
acetylsalicylic acid (D)
ibuprofen (a) (D)
paracetamol (D) 
acetylsalicylic acid*(C) (D)
colchicine
*probenecid
2.2 Opioid analgesics                                          
codeine (D) 
morphine (D) 
*pethidine
2.3 Medicines used to treat gout
allopurinol (D)
colchicine
2.4 Disease modifying agents used in rheumatoid disorders (DMARDs)
azathioprine (D)
chloroquine (D) 
cyclophosphamide
methotrexate (D)
penicillamine (D)
sulfasalazine (D)
azathioprine (D)
hydroxychloroquine
methotrexate (D) 
penicillamine (D) 
sulfasalazine (D)
2. TOTAL(core)
2. TOTAL

3. ANTIALLERGICS AND MEDICINES USED IN ANAPHYLAXIS
*chlorphenamine (a)
dexamethasone (D) 
epinephrine (adrenaline) (D) 
hydrocortisone (D) 
*prednisolone (D)
cromoglicic acid
3. TOTAL(core)
3. TOTAL

4. ANTIDOTES AND OTHER SUBSTANCES USED IN POISONING
4.1 Non-specific
charcoal, activated
ipecacuanha
4.2 Specific
acetylcysteine
atropine (D)
calcium gluconate (D)
deferoxamine
dimercaprol
DL-methionine
methylthioninium chloride (methylene blue)
naloxone
penicillamine (D) 
potassium ferric hexacyanoferrate (II) 2H2O (Prussian blue)
sodium calcium edetate
sodium nitrite
sodium thiosulfate (D)
methylthioninium chloride
penicillamine 
sodium calcium edetate
deferoxamine
dimercaprol
succimer
4. TOTAL(core)
4. TOTAL

5. ANTICONVULSANTS/ANTIEPILEPTICS
carbamazepine (D)
diazepam (D) 
* lorazepam
ethosuximide
magnesium sulfate
phenobarbital
phenytoin
valproic acid (D)
carbamazepine
*clonazepam
ethosuximide
magnesium sulfate
valproic acid
5. TOTAL(core)
5. TOTAL

6. ANTI-INFECTIVE MEDICINES
6.1 Anthelminthics
6.1.1 Intestinal anthelminthics
albendazole
levamisole
mebendazole
niclosamide
praziquantel (D) 
pyrantel
blephenium hydroxynaphthoate
levamisole
tetrachlorothylene
6.1.2 Antifilarials
albendazole (D)
diethylcarbamazine
ivermectin
diethylcarbamazine
ivermectin
suramin sodium (D)
6.1.3 Antischistosomals and antitrematode medicine
metrifonate
oxamniquine
praziquantel (D) 
triclabendazole
oxamniquine
sodium stibocaptate
6.2 Antibacterials
6.2.1 Beta Lactam medicines
*ceftriaxone (a)
*cloxacillin
amoxicillin
amoxicillin + clavulanic acid
ampicillin
benzathine benzylpenicillin
benzylpenicillin
Cefalexin ( C)
cefalozin (a)
cefixime
ceftazidime
imipenem + cilastatin
phenoxymethylpenicillin
procaine benzylpenicillin
amoxicillin + clavulanic acid
cefotaxime [c]
ceftazidime
*ceftriaxone
imipenem + cilastatin
6.2.2 Other antibacterials
azithromycin
clarithromycin
chloramphenicol
*ciprofloxacin (D)
doxycycline (a) (D) 
*erythromycin
*gentamicin (D) 
*metronidazole (D) 
nalidixic acid
nitrofurantoin
spectinomycin
sulfadiazine
sulfamethoxazole + trimethoprim (D)
trimethoprim (a)
vancomycin
amikacin
chloramphenicol
*ciprofloxacin
clindamycin
doxycycline
nalidixic acid
nitrofurantoin
procaine benzylpenicillin
sulfadiazine
trimethoprim
vancomycin
6.2.3 Antileprosy medicines
Medicines used in the treatment of leprosy should never be used except in combination. Combination therapy is essential to prevent the emergence of drug resistance. Colour coded blister packs (MDT blister packs) containing standard two medicine (paucibacillary leprosy) or three medicine (multibacillary leprosy) combinations for adult and childhood leprosy should be used. MDT blister packs can be supplied free of charge through WHO.
clofazimine
dapsone
rifampicin (D)
clofazimine
ethionamide
protionamide
rifampicin
6.2.4 Antituberculosis medicines
ethambutol
ethambutol + isoniazid 
ethambutol+ isoniazid+  rifampicin 
isoniazid
pyrazinamide
rifabutin
rifampicin (D)
rifampicin + isoniazid
rifampicin + isoniazid + pyrazinamide
rifampicin + isoniazid + pyrazinamide + ethambutol
streptomycin
Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
thioacetazone
thioacetazone + isoniazid
Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control
amikacin
p-aminosalicylic acid
capreomycin
ciprofloxacin (D) 
cycloserine
ethionamide
kanamycin
levofloxacin
ofloxacin
6.3 Antifungal medicines
amphotericin B (D)
clotrimazole
*fluconazole
griseofulvin
*ketoconazole
nystatin
amphotericin B (D)
flucytosine
potassium iodide (D) 
6.4 Antiviral medicines
6.4.1 Antiherpes medicines
*aciclovir (D)
6.4.2 Antiretrovirals
Based on current evidence and experience of use, medicines in the following three classes of antiretrovirals are included as esential medicines for treatment and prevention of HIV (prevention of mother-to-child transmission and post exposure prophylaxis). The Committee empasizes the importance of using these products in accordance with global and national guidelines. The Committee recommends and endorses the use of fixed-dose combinations and the development of appropiate new fixed-dose combinations, including modified dosage forms, non refrgerated products and paediatric dosage forms with assured pharmaceutical quality.

6.4.2.1 Nucleoside/nucleotide reverse transcriptase inhibitors
abacavir (ABC)
didanosine (ddI)
emtricitabine (FTC) (a)
lamivudine (3TC)
stavudine (d4T)
tenofovir disoproxil fumarate (TDF)
zidovudine (ZDV or AZT)

6.4.2.2 Non-nucleoside reverse transcriptase inhibitors
efavirenz (EFV or EFZ) (a)
nevirapine (NVP)

6.4.2.3 Protease inhibitors
Selection of protease inhibitor(s)b from the Model List will need to be determined by each country after consideration of international and  national treatment guidelines and experience. Ritonavir is recommended for use in combination as a pharmacollogicalbooster, and not as an antiretroviral in its own right. All other protease inhibitors should be used in boosted forms (e.g. with ritonavir)                                                                                                                                                                                            Thissection will be reviewed by the Committee as a priority at its next meeting. It is expected that application for a heat stable tablet formulation containing 200/50 mg lopinavir + ritonavir will be submitted for the next meeting.(2007)
atazanavir (a)
indinavir (IDV)
ritonavir
lopinavir + ritonavir (LPV/r)
nelfinavir (NFV)
saquinavir (SQV) (a)

FIXED-DOSE COMBINATIONS
efavirenz + emtricitabine + tenofovir
emtricitabine + tenofovir
lamivudine + neviparine + stavudine
zidovudine + lamivudine
zidovudine + lamivudine + nevirapine

6.4.3. Other antivirals
Oseltamivir 
ribavirin

6.5 Antiprotozoal medicines
6.5.1. Antiamoebic and antigiardiasis medicines
diloxanide (a)
*metronidazole (D) 
chloroquine 
dehydroemetine
diloxanide
emetine
paromomycin
6.5.2 Antileishmaniasis medicines
amphotericin B (D)
miltefosine
paromomycin
sodium stibogluconate or meglumine antimoniate
pentamidine (D)
amphotericin B (D)
pentamidine
6.5.3 Antimalarial medicines
6.5.3.1 For curative treatment
Medicines for the treatment of P. falciparum malaria cases should be used in combination. The list currently recommends combinations according to treatment guidelines. The Committee recognizes that not all of these FDCs exist and encourages their development and rigorous testing. The Committee also encourages development and testing of rectal dosage formulations.
amodiaquine
artemether
artemether + lumefantrine
artesunate
artesunate (D) + amodiaquine
chloroquine (D) 
doxycycline
mefloquine
primaquine
quinine
sulfadoxine + pyrimethamine
amodiaquine
doxycycline (D) 
mefloquine (D) 
sulfadoxine  
sulfadoxine + pyrimethamine
tetracycline
artemether
artesunate

6.5.3.2 For prophylaxis
chloroquine (D) 
doxycycline (D) (a)
mefloquine (D) (a)
proguanil
mefloquine
6.5.4 Anti-pneumocystosis and antitoxoplasmosis medicines
pentamidine (D)
pyrimethamine
sulfadiazine
sulfamethoxazole + trimethoprim (D)
pentamidine

6.5.5 Antitrypanosomal medicines
6.5.5.1 African trypanosomiasis
Medicines for the treatment of 1st stage African trypanosomiasis
pentamidine
suramin sodium (D)
Medicines for the treatment of 2nd stage African trypanosomiasis
eflornithine
melarsoprol
nifurtimox (D)
melarsoprol [C](D)
eflornithine
pentamidine
6.5.5.2 American trypanosomiasis
benznidazole
nifurtimox (D)
nifurtimox (D)
6.6 Insect repellents
diethyltoluamide
6. TOTAL(core)
6. TOTAL

7. ANTIMIGRAINE MEDICINES
7.1 For treatment of acute attack
acetylsalicylic acid (D)
ibuprofen [c] (D)
ergotamine
paracetamol (D) 
7.2 For prophylaxis
*propranolol
7. TOTAL(core)
7. TOTAL

8. ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
8.1 Immunosuppressive medicines
azathioprine (D)
ciclosporin
For use only when adequate resources and specialist care are available
azathioprine (D)
ciclosporin
8.2 Cytotoxic medicines 
asparaginase
bleomycin
calcium folinate
*carboplatin
chlorambucil
chlormethine
cisplatin
cyclophosphamide
cytarabine
dacarbazine
dactinomycin
daunorubicin
doxorubicin
etoposide
fluorouracil (D)
hydroxycarbamide
ifosfamide
levamisole 
mercaptopurine
mesna
methotrexate 
procarbazine
vinblastine
vincristine
Adequate resources and specialist oversight are a prerequisite for this class of drugs
allopurinol [c] (D)
asparaginase
bleomycin
calcium folinate
*carboplatin
chlorambucil
chlormethine
cisplatin
cyclophosphamide
cytarabine
dacarbazine
dactinomycin
daunorubicin
docetaxel
doxorubicin
etoposide
fluorouracil (D) 
hydroxycarbamide
ifosfamide
levamisole (D) 
mercaptopurine
mesna
methotrexate (D) 
paclitaxel
procarbazine
thioguanine[C]
vinblastine
vincristine

8.3 Hormones and antihormones 
*prednisolone (D)
tamoxifen
dexamethasone (D) 
hydrocortisone (D) 
methylprednisolone[C]
*prednisolone (D)
tamoxifen

8.4 Medicines used in palliative care [c]
The WHO Expert Committee recognizes the importance of listing specific medicines in the Palliative Care Section. Some medicines currently used in palliative care are included in the relevant sections of the Model List, according to their therapeutic use, e.g. analgesics. The Guidelines for Palliative Care that were referenced in the previous list are need of update. The Committee expects applications for medicines needed for palliative care to be submitted  for the next meeting. 
amitriptyline[c]
cyclizine[c]
dexamethasone[c]
diazepam[c]
docusate sodium[c]
fluoxetine[c]
hyoscine hydrobromide[c]
ibuprofen[c]
lactulose[c]
midazolam[c]
morphine[c]
ondansetron[c]
senna[c]
8. TOTAL(core)
8. TOTAL

9. ANTIPARKINSONISM MEDICINES
biperiden
levodopa + *carbidopa
levodopa
levodopa + *carbidopa
9. TOTAL(core)
9. TOTAL

10. MEDICINES AFFECTING THE BLOOD
10.1 Antianaemia medicines
ferrous salt
ferrous salt + folic acid
folic acid
hydroxocobalamin
ferrous salt + folic acid
iron dextran
10.2 Medicines affecting coagulation
desmopressin
heparin sodium (D)
phytomenadione
protamine sulfate (D)
tranexamic acid ©
*warfarin (D)
heparin sodium [c] (D) 
protamine sulfate [c] (D)
*warfarin [c] (D)
10.3 Other medicinies for haemoglobinopathies
deferoxamine
hydroxycarbamide


10. TOTAL(core)
10. TOTAL
11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
11.1 Plasma substitutes
*dextran 70
*polygeline
11.2 Plasma fractions for specific use
All plasma fractions should comply with the WHO Requirements for the Collection, Processing, and Quality Control of Blood, Blood Components, and Plasma Derivatives (Revised 1992). (WHO Technical Report Series, No. 840, 1994, Annex 2).
*factor VIII concentrate (complementary agent)
*factor IX complex (coagulation factors II, VII, IX, X) concentrate (complementary agent)
human normal immunoglobulin
*factor VIII concentrate
*factor IX complex (coagulation factors II, VII, IX, X) concentrate
fibrinogen
plasma proteins
11. TOTAL(core)
11. TOTAL

12. CARDIOVASCULAR MEDICINES
12.1 Antianginal medicines
*atenolol (D)
*bisoprolol (D)
glyceryl trinitrate
*isosorbide dinitrate
verapamil (D)
atenolol
12.2 Antiarrhythmic medicines
*atenolol (D)
*bisoprolol (D)
digoxin (D) 
epinephrine (adrenaline) (D) 
lidocaine (D) 
verapamil (D)
amiodarone
*atenolol
epinephrine (adrenaline)
isoprenaline
*procainamide
*quinidine

12.3 Antihypertensive medicines
*amlodipine
*atenolol (D)
*bisoprolol (D)
*enalapril (D) 
hydralazine
*hydrochlorothiazide (D) 
methyldopa
*nifedipine
*reserpine
*atenolol
*doxazosin
methyldopa
phentolamine
*prazosin
*reserpine
sodium nitroprusside

12.4 Medicines used in heart failure
*bisoprolol (D)
*captopril
digoxin (D) 
dopamine
*enalapril (D) 
*furosemide (D) 
*hydrochlorothiazide (D) 
digitoxin
isoprenaline
dopamine

12.5 Antithrombotic medicines
acetylsalicylic acid (D)
streptokinase

12.6 Lipid-lowering agents
*simvastatine
12. TOTAL(core)
12. TOTAL

13. DERMATOLOGICAL MEDICINES (TOPICAL)
13.1 Antifungal medicines
benzoic acid + salicylic acid
*miconazole
selenium sulfide
sodium thiosulfate (D)
terbinafine hydrochloride
selenium sulfide
13.2 Anti-infective medicines
*methylrosanilinium chloride (gentian violet)
mupirocin
neomycin 
neomycin sulfate + *bacitracin
potassium permanganate
silver sulfadiazine (a)
13.3 Anti-inflammatory and antipruritic medicines
*betamethasone (a)
*calamine 
*hydrocortisone (D) 
13.4 Astringent medicines
aluminium diacetate
podophyllin
13.4 Medicines affecting skin differentiation and proliferation
benzoyl peroxide
coal tar
dithranol
fluorouracil (D) 
*podophyllum resin
salicylic acid
urea
13.5 Scabicides and pediculicides
*benzyl benzoate (a)
permethrin
benzyl benzoate
13.6 Ultraviolet blocking agents 
topical sun protection agent with activity against ultraviolet A and ultraviolet B 
topical sun protection agent with activity against ultraviolet A and ultraviolet B
 - para-aminobenzoic acid
 - benzophenones
 - zinc oxide
13. TOTAL(core)
13. TOTAL

14. DIAGNOSTIC AGENTS
14.1 Ophthalmic medicines
fluorescein
*tropicamide
14.2 Radiocontrast media
*amidotrizoate
barium sulfate
*iohexol
*iopanoic acid
*propyliodone
barium sulfate [c]
iohexol
*meglumine iotroxate
14. TOTAL(core)
14. TOTAL

15. DISINFECTANTS AND ANTISEPTICS
15.1 Antiseptics
*chlorhexidine
*ethanol
*polyvidone iodine
15.2 Disinfectants
*chlorine base compound
*chloroxylenol
glutaral
*phenolic disinfectants
gentian violet
15. TOTAL(core)
15. TOTAL

16. DIURETICS
amiloride
*furosemide (D) 
*hydrochlorothiazide (D) 
mannitol (D)
spironolactone
chlorthalidone
mannitol (D)
spironolactone
triamterene
*hydrochlorothiazide [c]
mannitol [c] (D)
spironolactone [c]
16. TOTAL(core)
16. TOTAL

17. GASTROINTESTINAL MEDICINES
 17.1 Antiulcer Medicines
aluminium hydroxide
*cimetidine
* omeprazol
*ranitidine
magnesium hydroxide
calcium carbonate
*pancreatic enzymes [c]

17.2 Antiemetic medicines
dexamethasone (D)
metoclopramide (a)
ondansetron (a)
promethazine (D)
metoclopramide
17.3 Antihaemorrhoidal medicines
*local anaesthetic, astringent, and anti-inflammatory medicine

17.3 Anti-inflammatory medicines
*hydrocortisone 
*sulfasalazine (D)
*hydrocortisone (D) 

17.4 Antispasmodic medicines
*atropine

17.4 Laxatives
*senna

17.5 Medicines used in diarrhoea
17.5.1 Oral rehydration
oral rehydration salts (for glucose-electrolyte solution) (D) 


17.5.2 Medicines for diarrhoea in children
zinc sulfate

17.5.3 Antidiarrhoeal (symptomatic) medicines in adults
codeine (D) 
17. TOTAL(core)
17. TOTAL

18. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
18.1 Adrenal hormones and synthetic substitutes
Addison's disease is a rare condition; adrenal hormones are already included in section 3.
*dexamethasone 
fludrocortisone
hydrocortisone (D)
*prednisolone
fludrocortisone

18.2 Androgens
testosterone (complementary agent)
testosterone

18.3 Contraceptives
18.3.1 Oral hormonal contraceptives
*ethinylestradiol + *levonorgestrel
*ethinylestradiol + *norethisterone
levonorgestrel (D)
norethisterone enantate
*ethinylestradiol + *levonorgestrel
levonorgestrel
medroxyprogesterone acetate
norethisterone
norethisterone enantate

18.3.2 Injectable hormonal contraceptives
medroxyprogesterone acetate (D) 
medroxyprogesterone acetate + estradiol cypionate
norethisterone enantate

18.3.3 Intrauterine devices
copper-containing device

18.3.4 Barrier methods
condoms 
diaphragms 

18.3.5 Implantable contraceptives
levonorgestrel-releasing implant (D)

18.4 Estrogens
*ethinylestradiol

18.5 Insulins and other medicines used for diabetes
glibenclamide
glucagon
insulin
metformin
metformin [c]

18.6 Ovulation inducers
clomifene
clomifene

18.7 Progestogens
*medroxyprogesterone acetate (D) 
norethisterone
*medroxyprogesterone acetate (D) 
18.8 Thyroid hormones and antithyroid medicines
levothyroxine
potassium iodide (D) 
*propylthiouracil
Lugol's solution [c]
potassium iodide [c] (D)
propylthiouracil [c]
18. TOTAL(core)
18. TOTAL

19. IMMUNOLOGICALS
19.1 Diagnostic agents
All tuberculins should comply with the WHO Requirements for Tuberculins (Revised 1985). WHO Expert Committee on Biological Standardization Thirty-sixth report (WHO Technical Report Series, No. 745, 1987, Annex 1).
tuberculin, purified protein derivative (PPD)
19.2 Sera and immunoglobulins
All plasma fractions should comply with the WHO Requirements for the Collection, Processing and Quality Control of Blood, Blood Components and Plasma Derivatives (Revised 1992). WHO Expert Committee on Biological Standardization Forty-third report (WHO Technical Report Series, No. 840, 1994, Annex 2).
anti-D immunoglobulin (human)
antitetanus immunoglobulin (human)
antivenom immunoglobulin
diphtheria antitoxin
immunoglobulin, human normal
immunoglobulin, human normal
*rabies immunoglobulin
19.3 Vaccines
Selection of vaccines from the Model List will need to be determined by each country after consideration of international recommendations, epidemiology and national priorities. The list below details the vaccines for which there is either a recommendation from the Strategic Advisery Group of Experts on Immunization (SAGE) (http://www.who.int/immunization/sage_conclusions/en/index.html) and/or a WHO position paper (http://www.who.int/immunization/documents/positionpapers/en/index.html). This site will be updated as new position papers are published and contains the most recent information and recommendations.                                                                                                                  All vaccines should comply with the WHO Requirements for Biological Substances

19.3.1 For universal immunization
BCG vaccine
cholera vaccine
diphtheria vaccine
Haemophilus influenza type b vaccine
hepatitis A vaccine
hepatitis B vaccine
influenza vaccine
Japanese encephalitis vaccine
measles vaccine
meningococcal meningitis vaccine
mumps vaccine
pertussis vaccine
pneumococcal vaccine
poliomyelitis vaccine
rabies vaccine
rotavirus vaccine
rubella vaccine
tetanus vaccine
typhoid vaccine
varicella vaccine
yellow fever vaccine
19.3.2 For specific groups of individuals
19. TOTAL(core)
19. TOTAL

20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
*alcuronium
*atracurium
neostigmine
pyridostigmine
suxamethonium
* vecuronium [c]
pyridostigmine
*vecuronium
20. TOTAL(core)
20. TOTAL

21. OPHTHALMOLOGICAL PREPARATIONS
21.1 Anti-infective agents
aciclovir (D)
*gentamicin (D) 
*idoxuridine
silver nitrate
*tetracycline

21.2 Anti-inflammatory agents
*prednisolone (D)

21.3 Local anaesthetics
*tetracaine (a)

21.4 Miotics and antiglaucoma medicines
acetazolamide
*pilocarpine
*timolol
21.5 Mydriatics
atropine (D) (a)
epinephrine (adrenaline) (D) 
21. TOTAL(core)
21. TOTAL

22. OXYTOCICS AND ANTIOXYTOCICS
22.1 Oxytocics
*ergometrine
misoprostol
oxytocin
misoprostol
mifepristone - misoprostol (when permitted under national law and culturally aceptable)
22.2 Antioxytocics
*salbutamol
nifedipine
22. TOTAL(core)
22. TOTAL

23.PERITONEAL DIALYSIS SOLUTION
intraperitoneal dialysis solution (of appropriate composition)
intraperitoneal dialysis solution (of appropriate composition)
23. TOTAL(core)
23. TOTAL

24.Medicines  for mental and behavioural disorder
24.1 Medicines used in psychotic disorders
*chlorpromazine (D)
*fluphenazine
*haloperidol (D)
chlorpromazine [c] (D)
haloperidol [c] (D)
24.2 Medicines used in mood disorders
24.2.1 Medicines used in depressive disorders
*amitriptyline
fluoxetine (D)
fluoxetine (a) [c] (D)
24.2.2 Medicines used in bipolar disorders
carbamazepine (D)
lithium carbonate
valproic acid (D)
24.3 Medicines for anxiety disorders
*diazepam (D) 
24.4 Medicines used for obsessive compulsive disorders and panic attacks
clomipramine
24.5 Medicines for disorders due to psychoactive substance use
nicotine replacement therapy (NRT)
*methadone
24. TOTAL(core)
24. TOTAL

25. MEDICINES ACTING ON THE RESPIRATORY TRACT
25.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease
*aminophylline
*beclometasone
*budesonide [c] (D)
epinephrine (adrenaline) (D) 
ipratropium bromide
*salbutamol
theophylline
*aminophylline
beclometasone
*cromoglicic acid
ephedrine
25.2 Antitussives
25.2 Other medicines acting on the respiratory tract
caffeine citrate
*dextromethorphan
25. TOTAL(core)
25. TOTAL

26. SOLUTIONS CORRECTING WATER, ELECTROLYTE, AND ACID-BASE DISTURBANCES
26.1 Oral
oral rehydration salts (for glucose-electrolyte solution) (D) 
potassium chloride (D) 
26.2 Parenteral
glucose
glucose with sodium chloride
potassium chloride (D) 
sodium chloride
sodium hydrogen carbonate
*sodium lactate, compound solution
26.3 Miscellaneous
water for injection
26. TOTAL(core)
26. TOTAL

27. VITAMINS AND MINERALS
ascorbic acid
cholecalciferol [c]
*ergocalciferol
iodine
*nicotinamide
pyridoxine
retinol
riboflavin
sodium fluoride
thiamine
ascorbic acid
calcium gluconate (D)
27. TOTAL(core)
27. TOTAL

28. EAR, NOSE AND THROAT CONDITIONS IN CHILDREN (c )
acetic acid
*budesonide (D)
*ciprofloxacin (D)
*xylometazoline
28. TOTAL(core)
28. TOTAL

29. SPECIFIC MEDICINES FOR NEONATAL CARE (c )
caffeine citrate
*ibuprofen (D)
*prostaglandin E
surfactant
29. TOTAL(core)
29. TOTAL

GRAND TOTAL CORE INCLUDING DUPLICATES
GRAND TOTAL COMPLEMENTARY INCLUDING DUPLICATES
GRAND TOTAL CORE & COMPLEMENTARY INCLUDING DUPLICATES
DUPLICATES
GRAND TOTAL LESS DUPLICATES
Footnotes: 
Insulin appears on the list as soluble and intermediate- acting, counted as 1 molecule only 
In 2002, the term "drug" was replaced with "medicine" throughout.
In 2002, the abbreviation "ug" was replaced with "micrograms" throughout.
In 2002, ionic symbols (+ or -) added
In 2007, the terms suspension, syrup and elixer were replaced by "oral liquid" throughout. 
In 2009
(a) symbol indicates that there is an age restriction on use of the medicines
[c] symbol is placed next to the complementary list it signifies that the medicine(s) require(s) specialist diagnostic or monitoring facilities,and/or specialist medical care, and/or specialist training for their use in children.
[c] symbol is placed next to an individual medicine or strength of medicine it signifies that there is a specific indication for restricting its use to children.



italics

(D)

potassium iodide (D) 
6.4 Antiviral medicines
6.4.1 Antiherpes medicines
*aciclovir (D)
6.4.2 Antiretrovirals
Based on current evidence and experience of use, medicines in the following three classes of antiretrovirals are included as esential medicines for treatment and prevention of HIV (prevention of mother-to-child transmission and post exposure prophylaxis). The Committee empasizes the importance of using these products in accordance with global and national guidelines. The Committee recommends and endorses the use of fixed-dose combinations and the development of appropiate new fixed-dose combinations, including modified dosage forms, non refrgerated products and paediatric dosage forms with assured pharmaceutical quality.

6.4.2.1 Nucleoside/nucleotide reverse transcriptase inhibitors
abacavir (ABC)
didanosine (ddI)
emtricitabine (FTC) (a)
lamivudine (3TC)
stavudine (d4T)
tenofovir disoproxil fumarate (TDF)
zidovudine (ZDV or AZT)

6.4.2.2 Non-nucleoside reverse transcriptase inhibitors
efavirenz (EFV or EFZ) (a)
nevirapine (NVP)

6.4.2.3 Protease inhibitors
Selection of protease inhibitor(s)b from the Model List will need to be determined by each country after consideration of international and  national treatment guidelines and experience. Ritonavir is recommended for use in combination as a pharmacollogicalbooster, and not as an antiretroviral in its own right. All other protease inhibitors should be used in boosted forms (e.g. with ritonavir)                                                                                                                                                                                            Thissection will be reviewed by the Committee as a priority at its next meeting. It is expected that application for a heat stable tablet formulation containing 200/50 mg lopinavir + ritonavir will be submitted for the next meeting.(2007)
atazanavir (a)
indinavir (IDV)
ritonavir
lopinavir + ritonavir (LPV/r)
nelfinavir (NFV)
saquinavir (SQV) (a)

FIXED-DOSE COMBINATIONS
efavirenz + emtricitabine + tenofovir
emtricitabine + tenofovir
lamivudine + neviparine + stavudine
zidovudine + lamivudine
zidovudine + lamivudine + nevirapine

6.4.3. Other antivirals
Oseltamivir 
ribavirin

6.5 Antiprotozoal medicines
6.5.1. Antiamoebic and antigiardiasis medicines
diloxanide (a)
*metronidazole (D) 
chloroquine 
dehydroemetine
diloxanide
emetine
paromomycin
6.5.2 Antileishmaniasis medicines
amphotericin B (D)
miltefosine
paromomycin
sodium stibogluconate or meglumine antimoniate
pentamidine (D)
amphotericin B (D)
pentamidine
6.5.3 Antimalarial medicines
6.5.3.1 For curative treatment
Medicines for the treatment of P. falciparum malaria cases should be used in combination. The list currently recommends combinations according to treatment guidelines. The Committee recognizes that not all of these FDCs exist and encourages their development and rigorous testing. The Committee also encourages development and testing of rectal dosage formulations.
amodiaquine
artemether
artemether + lumefantrine
artesunate
artesunate (D) + amodiaquine
chloroquine (D) 
doxycycline
mefloquine
primaquine
quinine
sulfadoxine + pyrimethamine
amodiaquine
doxycycline (D) 
mefloquine (D) 
sulfadoxine  
sulfadoxine + pyrimethamine
tetracycline
artemether
artesunate

6.5.3.2 For prophylaxis
chloroquine (D) 
doxycycline (D) (a)
mefloquine (D) (a)
proguanil
mefloquine
6.5.4 Anti-pneumocystosis and antitoxoplasmosis medicines
pentamidine (D)
pyrimethamine
sulfadiazine
sulfamethoxazole + trimethoprim (D)
pentamidine

6.5.5 Antitrypanosomal medicines
6.5.5.1 African trypanosomiasis
Medicines for the treatment of 1st stage African trypanosomiasis
pentamidine
suramin sodium (D)
Medicines for the treatment of 2nd stage African trypanosomiasis
eflornithine
melarsoprol
nifurtimox (D)
melarsoprol [C](D)
eflornithine
pentamidine
6.5.5.2 American trypanosomiasis
benznidazole
nifurtimox (D)
nifurtimox (D)
6.6 Insect repellents
diethyltoluamide
6. TOTAL(core)
6. TOTAL

7. ANTIMIGRAINE MEDICINES
7.1 For treatment of acute attack
acetylsalicylic acid (D)
ibuprofen [c] (D)
ergotamine
paracetamol (D) 
7.2 For prophylaxis
*propranolol
7. TOTAL(core)
7. TOTAL

8. ANTINEOPLASTIC, IMMUNOSUPPRESSIVES AND MEDICINES USED IN PALLIATIVE CARE
8.1 Immunosuppressive medicines
azathioprine (D)
ciclosporin
For use only when adequate resources and specialist care are available
azathioprine (D)
ciclosporin
8.2 Cytotoxic medicines 
asparaginase
bleomycin
calcium folinate
*carboplatin
chlorambucil
chlormethine
cisplatin
cyclophosphamide
cytarabine
dacarbazine
dactinomycin
daunorubicin
doxorubicin
etoposide
fluorouracil (D)
hydroxycarbamide
ifosfamide
levamisole 
mercaptopurine
mesna
methotrexate 
procarbazine
vinblastine
vincristine
Adequate resources and specialist oversight are a prerequisite for this class of drugs
allopurinol [c] (D)
asparaginase
bleomycin
calcium folinate
*carboplatin
chlorambucil
chlormethine
cisplatin
cyclophosphamide
cytarabine
dacarbazine
dactinomycin
daunorubicin
docetaxel
doxorubicin
etoposide
fluorouracil (D) 
hydroxycarbamide
ifosfamide
levamisole (D) 
mercaptopurine
mesna
methotrexate (D) 
paclitaxel
procarbazine
thioguanine[C]
vinblastine
vincristine

8.3 Hormones and antihormones 
*prednisolone (D)
tamoxifen
dexamethasone (D) 
hydrocortisone (D) 
methylprednisolone[C]
*prednisolone (D)
tamoxifen

8.4 Medicines used in palliative care [c]
The WHO Expert Committee recognizes the importance of listing specific medicines in the Palliative Care Section. Some medicines currently used in palliative care are included in the relevant sections of the Model List, according to their therapeutic use, e.g. analgesics. The Guidelines for Palliative Care that were referenced in the previous list are need of update. The Committee expects applications for medicines needed for palliative care to be submitted  for the next meeting. 
amitriptyline[c]
cyclizine[c]
dexamethasone[c]
diazepam[c]
docusate sodium[c]
fluoxetine[c]
hyoscine hydrobromide[c]
ibuprofen[c]
lactulose[c]
midazolam[c]
morphine[c]
ondansetron[c]
senna[c]
8. TOTAL(core)
8. TOTAL

9. ANTIPARKINSONISM MEDICINES
biperiden
levodopa + *carbidopa
levodopa
levodopa + *carbidopa
9. TOTAL(core)
9. TOTAL

10. MEDICINES AFFECTING THE BLOOD
10.1 Antianaemia medicines
ferrous salt
ferrous salt + folic acid
folic acid
hydroxocobalamin
ferrous salt + folic acid
iron dextran
10.2 Medicines affecting coagulation
desmopressin
heparin sodium (D)
phytomenadione
protamine sulfate (D)
tranexamic acid ©
*warfarin (D)
heparin sodium [c] (D) 
protamine sulfate [c] (D)
*warfarin [c] (D)
10.3 Other medicinies for haemoglobinopathies
deferoxamine
hydroxycarbamide


10. TOTAL(core)
10. TOTAL
11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES
11.1 Plasma substitutes
*dextran 70
*polygeline
11.2 Plasma fractions for specific use
All plasma fractions should comply with the WHO Requirements for the Collection, Processing, and Quality Control of Blood, Blood Components, and Plasma Derivatives (Revised 1992). (WHO Technical Report Series, No. 840, 1994, Annex 2).
*factor VIII concentrate (complementary agent)
*factor IX complex (coagulation factors II, VII, IX, X) concentrate (complementary agent)
human normal immunoglobulin
*factor VIII concentrate
*factor IX complex (coagulation factors II, VII, IX, X) concentrate
fibrinogen
plasma proteins
11. TOTAL(core)
11. TOTAL

12. CARDIOVASCULAR MEDICINES
12.1 Antianginal medicines
*atenolol (D)
*bisoprolol (D)
glyceryl trinitrate
*isosorbide dinitrate
verapamil (D)
atenolol
12.2 Antiarrhythmic medicines
*atenolol (D)
*bisoprolol (D)
digoxin (D) 
epinephrine (adrenaline) (D) 
lidocaine (D) 
verapamil (D)
amiodarone
*atenolol
epinephrine (adrenaline)
isoprenaline
*procainamide
*quinidine

12.3 Antihypertensive medicines
*amlodipine
*atenolol (D)
*bisoprolol (D)
*enalapril (D) 
hydralazine
*hydrochlorothiazide (D) 
methyldopa
*nifedipine
*reserpine
*atenolol
*doxazosin
methyldopa
phentolamine
*prazosin
*reserpine
sodium nitroprusside

12.4 Medicines used in heart failure
*bisoprolol (D)
*captopril
digoxin (D) 
dopamine
*enalapril (D) 
*furosemide (D) 
*hydrochlorothiazide (D) 
digitoxin
isoprenaline
dopamine

12.5 Antithrombotic medicines
acetylsalicylic acid (D)
streptokinase

12.6 Lipid-lowering agents
*simvastatine
12. TOTAL(core)
12. TOTAL

13. DERMATOLOGICAL MEDICINES (TOPICAL)
13.1 Antifungal medicines
benzoic acid + salicylic acid
*miconazole
selenium sulfide
sodium thiosulfate (D)
terbinafine hydrochloride
selenium sulfide
13.2 Anti-infective medicines
*methylrosanilinium chloride (gentian violet)
mupirocin
neomycin 
neomycin sulfate + *bacitracin
potassium permanganate
silver sulfadiazine (a)
13.3 Anti-inflammatory and antipruritic medicines
*betamethasone (a)
*calamine 
*hydrocortisone (D) 
13.4 Astringent medicines
aluminium diacetate
podophyllin
13.4 Medicines affecting skin differentiation and proliferation
benzoyl peroxide
coal tar
dithranol
fluorouracil (D) 
*podophyllum resin
salicylic acid
urea
13.5 Scabicides and pediculicides
*benzyl benzoate (a)
permethrin
benzyl benzoate
13.6 Ultraviolet blocking agents 
topical sun protection agent with activity against ultraviolet A and ultraviolet B 
topical sun protection agent with activity against ultraviolet A and ultraviolet B
 - para-aminobenzoic acid
 - benzophenones
 - zinc oxide
13. TOTAL(core)
13. TOTAL

14. DIAGNOSTIC AGENTS
14.1 Ophthalmic medicines
fluorescein
*tropicamide
14.2 Radiocontrast media
*amidotrizoate
barium sulfate
*iohexol
*iopanoic acid
*propyliodone
barium sulfate [c]
iohexol
*meglumine iotroxate
14. TOTAL(core)
14. TOTAL

15. DISINFECTANTS AND ANTISEPTICS
15.1 Antiseptics
*chlorhexidine
*ethanol
*polyvidone iodine
15.2 Disinfectants
*chlorine base compound
*chloroxylenol
glutaral
*phenolic disinfectants
gentian violet
15. TOTAL(core)
15. TOTAL

16. DIURETICS
amiloride
*furosemide (D) 
*hydrochlorothiazide (D) 
mannitol (D)
spironolactone
chlorthalidone
mannitol (D)
spironolactone
triamterene
*hydrochlorothiazide [c]
mannitol [c] (D)
spironolactone [c]
16. TOTAL(core)
16. TOTAL

17. GASTROINTESTINAL MEDICINES
 17.1 Antiulcer Medicines
aluminium hydroxide
*cimetidine
* omeprazol
*ranitidine
magnesium hydroxide
calcium carbonate
*pancreatic enzymes [c]

17.2 Antiemetic medicines
dexamethasone (D)
metoclopramide (a)
ondansetron (a)
promethazine (D)
metoclopramide
17.3 Antihaemorrhoidal medicines
*local anaesthetic, astringent, and anti-inflammatory medicine

17.3 Anti-inflammatory medicines
*hydrocortisone 
*sulfasalazine (D)
*hydrocortisone (D) 

17.4 Antispasmodic medicines
*atropine

17.4 Laxatives
*senna

17.5 Medicines used in diarrhoea
17.5.1 Oral rehydration
oral rehydration salts (for glucose-electrolyte solution) (D) 


17.5.2 Medicines for diarrhoea in children
zinc sulfate

17.5.3 Antidiarrhoeal (symptomatic) medicines in adults
codeine (D) 
17. TOTAL(core)
17. TOTAL

18. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES
18.1 Adrenal hormones and synthetic substitutes
Addison's disease is a rare condition; adrenal hormones are already included in section 3.
*dexamethasone 
fludrocortisone
hydrocortisone (D)
*prednisolone
fludrocortisone

18.2 Androgens
testosterone (complementary agent)
testosterone

18.3 Contraceptives
18.3.1 Oral hormonal contraceptives
*ethinylestradiol + *levonorgestrel
*ethinylestradiol + *norethisterone
levonorgestrel (D)
norethisterone enantate
*ethinylestradiol + *levonorgestrel
levonorgestrel
medroxyprogesterone acetate
norethisterone
norethisterone enantate

18.3.2 Injectable hormonal contraceptives
medroxyprogesterone acetate (D) 
medroxyprogesterone acetate + estradiol cypionate
norethisterone enantate

18.3.3 Intrauterine devices
copper-containing device

18.3.4 Barrier methods
condoms 
diaphragms 

18.3.5 Implantable contraceptives
levonorgestrel-releasing implant (D)

18.4 Estrogens
*ethinylestradiol

18.5 Insulins and other medicines used for diabetes
glibenclamide
glucagon
insulin
metformin
metformin [c]

18.6 Ovulation inducers
clomifene
clomifene

18.7 Progestogens
*medroxyprogesterone acetate (D) 
norethisterone
*medroxyprogesterone acetate (D) 
18.8 Thyroid hormones and antithyroid medicines
levothyroxine
potassium iodide (D) 
*propylthiouracil
Lugol's solution [c]
potassium iodide [c] (D)
propylthiouracil [c]
18. TOTAL(core)
18. TOTAL

19. IMMUNOLOGICALS
19.1 Diagnostic agents
All tuberculins should comply with the WHO Requirements for Tuberculins (Revised 1985). WHO Expert Committee on Biological Standardization Thirty-sixth report (WHO Technical Report Series, No. 745, 1987, Annex 1).
tuberculin, purified protein derivative (PPD)
19.2 Sera and immunoglobulins
All plasma fractions should comply with the WHO Requirements for the Collection, Processing and Quality Control of Blood, Blood Components and Plasma Derivatives (Revised 1992). WHO Expert Committee on Biological Standardization Forty-third report (WHO Technical Report Series, No. 840, 1994, Annex 2).
anti-D immunoglobulin (human)
antitetanus immunoglobulin (human)
antivenom immunoglobulin
diphtheria antitoxin
immunoglobulin, human normal
immunoglobulin, human normal
*rabies immunoglobulin
19.3 Vaccines
Selection of vaccines from the Model List will need to be determined by each country after consideration of international recommendations, epidemiology and national priorities. The list below details the vaccines for which there is either a recommendation from the Strategic Advisery Group of Experts on Immunization (SAGE) (http://www.who.int/immunization/sage_conclusions/en/index.html) and/or a WHO position paper (http://www.who.int/immunization/documents/positionpapers/en/index.html). This site will be updated as new position papers are published and contains the most recent information and recommendations.                                                                                                                  All vaccines should comply with the WHO Requirements for Biological Substances

19.3.1 For universal immunization
BCG vaccine
cholera vaccine
diphtheria vaccine
Haemophilus influenza type b vaccine
hepatitis A vaccine
hepatitis B vaccine
influenza vaccine
Japanese encephalitis vaccine
measles vaccine
meningococcal meningitis vaccine
mumps vaccine
pertussis vaccine
pneumococcal vaccine
poliomyelitis vaccine
rabies vaccine
rotavirus vaccine
rubella vaccine
tetanus vaccine
typhoid vaccine
varicella vaccine
yellow fever vaccine
19.3.2 For specific groups of individuals
19. TOTAL(core)
19. TOTAL

20. MUSCLE RELAXANTS (PERIPHERALLY ACTING) AND CHOLINESTERASE INHIBITORS
*alcuronium
*atracurium
neostigmine
pyridostigmine
suxamethonium
* vecuronium [c]
pyridostigmine
*vecuronium
20. TOTAL(core)
20. TOTAL

21. OPHTHALMOLOGICAL PREPARATIONS
21.1 Anti-infective agents
aciclovir (D)
*gentamicin (D) 
*idoxuridine
silver nitrate
*tetracycline

21.2 Anti-inflammatory agents
*prednisolone (D)

21.3 Local anaesthetics
*tetracaine (a)

21.4 Miotics and antiglaucoma medicines
acetazolamide
*pilocarpine
*timolol
21.5 Mydriatics
atropine (D) (a)
epinephrine (adrenaline) (D) 
21. TOTAL(core)
21. TOTAL

22. OXYTOCICS AND ANTIOXYTOCICS
22.1 Oxytocics
*ergometrine
misoprostol
oxytocin
misoprostol
mifepristone - misoprostol (when permitted under national law and culturally aceptable)
22.2 Antioxytocics
*salbutamol
nifedipine
22. TOTAL(core)
22. TOTAL

23.PERITONEAL DIALYSIS SOLUTION
intraperitoneal dialysis solution (of appropriate composition)
intraperitoneal dialysis solution (of appropriate composition)
23. TOTAL(core)
23. TOTAL

24.Medicines  for mental and behavioural disorder
24.1 Medicines used in psychotic disorders
*chlorpromazine (D)
*fluphenazine
*haloperidol (D)
chlorpromazine [c] (D)
haloperidol [c] (D)
24.2 Medicines used in mood disorders
24.2.1 Medicines used in depressive disorders
*amitriptyline
fluoxetine (D)
fluoxetine (a) [c] (D)
24.2.2 Medicines used in bipolar disorders
carbamazepine (D)
lithium carbonate
valproic acid (D)
24.3 Medicines for anxiety disorders
*diazepam (D) 
24.4 Medicines used for obsessive compulsive disorders and panic attacks
clomipramine
24.5 Medicines for disorders due to psychoactive substance use
nicotine replacement therapy (NRT)
*methadone
24. TOTAL(core)
24. TOTAL

25. MEDICINES ACTING ON THE RESPIRATORY TRACT
25.1 Antiasthmatic and medicines for chronic obstructive pulmonary disease
*aminophylline
*beclometasone
*budesonide [c] (D)
epinephrine (adrenaline) (D) 
ipratropium bromide
*salbutamol
theophylline
*aminophylline
beclometasone
*cromoglicic acid
ephedrine
25.2 Antitussives
25.2 Other medicines acting on the respiratory tract
caffeine citrate
*dextromethorphan
25. TOTAL(core)
25. TOTAL

26. SOLUTIONS CORRECTING WATER, ELECTROLYTE, AND ACID-BASE DISTURBANCES
26.1 Oral
oral rehydration salts (for glucose-electrolyte solution) (D) 
potassium chloride (D) 
26.2 Parenteral
glucose
glucose with sodium chloride
potassium chloride (D) 
sodium chloride
sodium hydrogen carbonate
*sodium lactate, compound solution
26.3 Miscellaneous
water for injection
26. TOTAL(core)
26. TOTAL

27. VITAMINS AND MINERALS
ascorbic acid
cholecalciferol [c]
*ergocalciferol
iodine
*nicotinamide
pyridoxine
retinol
riboflavin
sodium fluoride
thiamine
ascorbic acid
calcium gluconate (D)
27. TOTAL(core)
27. TOTAL

28. EAR, NOSE AND THROAT CONDITIONS IN CHILDREN (c )
acetic acid
*budesonide (D)
*ciprofloxacin (D)
*xylometazoline
28. TOTAL(core)
28. TOTAL

29. SPECIFIC MEDICINES FOR NEONATAL CARE (c )
caffeine citrate
*ibuprofen (D)
*prostaglandin E
surfactant
29. TOTAL(core)
29. TOTAL

GRAND TOTAL CORE INCLUDING DUPLICATES
GRAND TOTAL COMPLEMENTARY INCLUDING DUPLICATES
GRAND TOTAL CORE & COMPLEMENTARY INCLUDING DUPLICATES
DUPLICATES
GRAND TOTAL LESS DUPLICATES
Footnotes: 
Insulin appears on the list as soluble and intermediate- acting, counted as 1 molecule only 
In 2002, the term "drug" was replaced with "medicine" throughout.
In 2002, the abbreviation "ug" was replaced with "micrograms" throughout.
In 2002, ionic symbols (+ or -) added
In 2007, the terms suspension, syrup and elixer were replaced by "oral liquid" throughout. 
In 2009
(a) symbol indicates that there is an age restriction on use of the medicines
[c] symbol is placed next to the complementary list it signifies that the medicine(s) require(s) specialist diagnostic or monitoring facilities,and/or specialist medical care, and/or specialist training for their use in children.
[c] symbol is placed next to an individual medicine or strength of medicine it signifies that there is a specific indication for restricting its use to children.



italics

(D)

